Nevro Leadership

Portrait

D. Keith Grossman Chairman, Ceo & President

Full Bio

D. Keith Grossman was named CEO and President of Nevro in March of 2019. Mr. Grossman has over 30 years of experience in the medical device field. He served most recently, and for the second time, as the President, Chief Executive Officer and director of Thoratec Corporation, leading up to its 2015 sale to St. Jude Medical. Prior to Thoratec, he served as President, Chief Executive Officer and director of Conceptus, a women’s health medical device company, leading up to its sale to Bayer Healthcare. Prior to Conceptus, Mr. Grossman served as managing director of TPG (Texas Pacific Group), a private equity firm, as a member of its healthcare investment team. Prior to TPG, Mr. Grossman served as Thoratec’s President, Chief Executive Officer and director for the first ten years of its growth as a commercial company. Mr. Grossman currently serves as Vice Chairman of Alcon, Inc., Chairman of Outset Medical, Inc. (privately held), and Board member of ViewRay, Inc. and previously served as a member of the Board of directors of Intuitive Surgical, Inc., Kyphon, Inc., Zeltiq, Inc and a number of privately held medical device companies. Mr. Grossman received a B.S. in life sciences from The Ohio State University and an M.B.A. from Pepperdine University.

Portrait

Andrew Galligan Chief Financial Officer

Full Bio

Andrew Galligan joined Nevro in 2010 and is Chief Financial Officer of the Company. Prior to joining Nevro, Mr. Galligan held the same position at OOMA, a consumer electronics manufacturer and VOIP service provider. Prior to that, Mr. Galligan was Vice President Finance and Chief Financial Officer of Reliant Technologies, a pioneer of fractional resurfacing skin treatments with aesthetic lasers. Mr. Galligan has also held the top financial executive position at several other medical device companies bringing to Nevro many years of experience in the commercialization of innovative medical therapeutic and diagnostic technologies. Mr. Galligan began his career in various financial positions at KPMG, and Raychem. Mr. Galligan received his degree in Business Studies from Trinity College in Dublin, Ireland, and he is also a Fellow of the Institute of Chartered Accountants in Ireland.

Portrait

David CarawayMD, PhD Chief Medical Officer

Full Bio

David Caraway, MD, PhD joined Nevro in 2014 and serves as Nevro’s Chief Medical Officer. Prior to joining Nevro, Dr. Caraway was the CEO of The Center for Pain Relief, Tri-State, L.L.C., in partnership with St. Mary’s Regional Medical Center in Huntington, West Virginia. Dr. Caraway has maintained an active medical practice for over 20 years and has held leadership positions in the North American Neuromodulation and the American Society of Interventional Pain Physicians. As a nationally recognized expert in the treatment of chronic pain, he has lectured regionally, nationally, and internationally in the field of Interventional Pain Medicine and authored numerous publications in this field. Dr. Caraway received a BS in Chemical Engineering from the University of Virginia School of Engineering, an MD from the University of Virginia School of Medicine, and a PhD in Biophysics from the University of Virginia Graduate School of Arts and Sciences. He also received post-graduate training in Anesthesiology and Pain Management from the University of Virginia. Dr. Caraway is board certified by the American Board of Anesthesiology.

Portrait

Kashif Rashid General Counsel

Full Bio

Kashif Rashid joined Nevro in 2017 and serves as General Counsel of the company. Mr. Rashid joins us with over 19 years of broad legal experience in medical devices, healthcare and private law practice. Mr. Rashid recently served as Deputy General Counsel at St. Jude Medical, a medical device company, where he had responsibility for various aspects of the legal function, including commercial, business development and corporate governance and securities. Following the acquisition of St. Jude Medical by Abbott, Mr. Rashid moved to Atara Biotherapeutics, a bay-area biotech focused on T-cell immunotherapy, as Vice President, Legal. Prior to St. Jude Medical, Mr. Rashid served in roles of increasing responsibility at General Electric's Healthcare business, Loews Corporation and Kaye Scholer, LLP. Mr. Rashid received his Bachelor of Business Administration from the George Washington University and his JD from Georgetown University Law Center.

Portrait

Niamh Pellegrini Chief Commercial Officer

Full Bio

 Niamh Pellegrini is a proven commercial leader with 20 years of experience in the healthcare industry. Prior to joining Nevro, Ms. Pellegrini was Vice President of Global Commercial Operations for Abbott Vascular, where she was responsible for driving approximately $3B in revenue. Prior to Abbott, Ms. Pellegrini served as CEO and President at Autonomic Technologies, Inc., where she led a turnaround of its European commercial business and drove U.S. market access. Previously, Ms. Pellegrini was President, North America at Thoratec Corporation, where she helped return the company to growth prior to its acquisition. Prior to joining Thoratec Corporation, Ms. Pellegrini served in progressively responsible global business development, strategy and commercial roles at Johnson & Johnson. Niamh Pellegrini graduated from Santa Clara University with an M.B.A and a B.S. in finance.

Portrait

Lori Ciano Chief Human Resources Officer

Full Bio

Lori Ciano joined Nevro in June of 2019 and serves as Chief Human Resources Officer. Ms Ciano brings more than 15 years of experience as a senior human resources leader in both the life sciences and technology industries. Prior to joining Nevro, Ms. Ciano was Senior Vice President, Human Resources at Dermira, a Menlo Park-based biotechnology company. Prior to Dermira, Lori served as a consultant specializing in coaching and counsel around talent acquisition and management, compensation and benefits, and culture to executive and HR teams. Previously, she served as Vice President of Information Technology and Chief Human Resources Officer at Thoratec Corporation. Ms. Ciano has also led HR organizations at Conceptus, Affymetrix, and Novellus Systems. She began her career at Varian where she served in marketing and business development roles. Lori Ciano earned an M.S. in psychology from JFK University, an M.B.A. from Santa Clara University, and a B.S. in marketing from San José State University.

Portrait

Michael Carter Vice President, Global Sales

Full Bio

Michael Carter joined Nevro in 2019, and serves as Vice President of Global Sales. Prior to Nevro, Mr. Carter held several commercial and general management leadership positions at Stryker, including Vice President/General Manager for Stryker Spine from 2017 to 2018, Vice President/General Manager for Stryker Joint Replacement from 2012 to 2017, Vice President/General Manager for Stryker OtisMed from 2012 to 2014, and Vice President Sales & Marketing for the Craniomaxillofacial division from 2009 to 2012. From 2000 to 2009, Mr. Carter held roles of increasing responsibility in sales in the Craniomaxillofacial division. Mr. Carter received his BS from the US Military Academy at West Point and served in the US Army as a Field Artillery Officer.

Portrait

Richard B. Carter Vice President, Finance, Corporate Controller

Full Bio

Richard B. Carter joined Nevro in 2014 and serves as Vice President of Finance, Corporate Controller of the company. He has held roles of increasing responsibility in finance and accounting since joining Nevro as Corporate Controller in September 2014. From October 2013 to October 2014, Mr. Carter served as Corporate Controller at ClearEdge Power, Inc., a privately held fuel cell manufacturing company. From December 2011 to October 2013, Mr. Carter served as the Vice President of Finance and Corporate Controller at Kovio, Inc., a privately held electronic device manufacturing company. From March 2007 to December 2011, Mr. Carter served as Vice President of Finance and Corporate Controller at MiaSolé, a thin-film solar panel manufacturer. Previously, Mr. Carter served as the Corporate Controller at PortalPlayer, Inc. and Transmeta Corporation, both publicly traded fabless semiconductor companies. Mr. Carter received a B.S. in Business Administration from California State University, Chico. Mr. Carter is a Certified Public Accountant and began his career as an auditor at Ernst & Young, LLP.

Portrait

Christofer Christoforou Vice President, Research And Development

Full Bio

Christofer Christoforou joined Nevro in 2016 and serves as Vice President, R&D. Prior to joining Nevro, Mr. Christoforou served as Vice President, Quality Engineering at Thoratec Corporation, a medical device company where he oversaw the operational, design and supplier quality engineering functions. From October 1999 to December 2014, Mr. Christoforou served in several leadership positions of increasing levels of responsibility at Thoratec Corporation. From April 1993 to October 1999, Mr. Christoforou served as a Manager of Engineering and various Engineering positions for United States Surgical Corporation, a producer of tools for use in surgery. Mr. Christoforou received a BS in Biomedical Engineering from Boston University and a MS in Biomedical Engineering from Johns Hopkins University in Maryland.

Portrait

Juliet Cunningham Vice President, Investor Relations

Full Bio

Juliet Cunningham joined Nevro in 2019 and serves as Vice President, Investor Relations. Ms. Cunningham brings two decades of healthcare and technology investor relations experience, most recently as Vice President, Investor Relations at point-of-care diagnostics leader Alere. Prior to Alere, Ms. Cunningham led investor relations and corporate communications at Lytx, Mitek and Novatel Wireless. Ms. Cunningham began her investor relations career at QUALCOMM, where she held positions of increasing responsibility during a decade of the company’s rapid growth. As Senior Vice President, Ms. Cunningham developed and executed global communications programs to target and manage relationships with institutional investors, equity analysts and financial media. Ms. Cunningham holds a bachelor’s degree in Business Administration from the University of Phoenix/Pepperdine University and completed her investor relations certification at the University of Michigan.

Portrait

Donald A. Middlebrook Vice President, Clinical, Regulatory and Quality

Full Bio

Donald Middlebrook joined Nevro in January 2020 and has over 30 years of leadership experience gaining global regulatory approvals, managing significant risk clinical trials and overseeing multi-site quality assurance/compliance programs for complex Class II and III medical device companies. He served most recently as a Regulatory and Clinical Affairs Consultant for St. Jude Medical following their acquisition of Thoratec Corporation in October 2015 and then for Abbott from January 2017 when the company acquired St. Jude Medical. Prior to this, Mr. Middlebrook served as Vice President of Corporate Quality and Regulatory Affairs for Thoratec. In the span of 19 years, he was responsible for worldwide regulatory approvals, leading numerous groundbreaking clinical trials and overseeing the company’s quality system activities. Before joining Thoratec, Mr. Middlebrook was Senior Director, Global Regulatory Affairs and Quality Assurance for Chiron Vision, involved in the manufacturing of ophthalmic surgical devices. Mr. Middlebrook spent 15 years with Baxter International in several progressing positions including Vice President of Regulatory Affairs and Quality Assurance for the Cardiovascular Group (now known as Edwards Lifesciences). Mr. Middlebrook previously served as President and Chairman of the Regulatory Affairs Professional Society (RAPS) Board of Directors, was elected as a RAPS Fellow and has continued to serve on several important committees for this society. Donald Middlebrook received a B.S. in Biology from California State University, Fullerton.

Portrait

Patrick Schmitz Vice President, Operations

Full Bio

Patrick Schmitz joined Nevro in 2016 and serves as Vice President, Operations. Prior to joining Nevro and since July 2005, Mr. Schmitz served as Vice President, Operations at Thoratec Corporation, a medical device company where he oversaw all domestic and international operations. From March 2003 to July 2005, Mr. Schmitz served as Vice President, North American Operations at GN ReSound, a medical device company. Mr. Schmitz also held several leadership positions in increasing levels of responsibility at St. Jude from March 1993 through March 2003. Mr. Schmitz holds a BS in Industrial Technology from the University of Wisconsin – Stout.

Portrait

Claire Smith Vice President, Therapy Optimization

Full Bio

Claire Smith joined Nevro in 2011 and serves as the Vice President of Therapy Optimization. Ms. Smith has held roles of increasing responsibility in Sales, Sales Leadership, Strategic Education and Therapy Optimization across the United States, Europe and Australia since joining Nevro. Prior to joining Nevro, Ms. Smith served as a UK Sales Specialist for ApaTech Ltd, a medical device company manufacturing and supplying a synthetic bone graft, where she successfully launched Actifuse into a previously unserved area of the UK. Prior to ApaTech, Ms. Smith held Sales roles for Janseen Cilag, a Johnson & Johnson Company, in the Pain and Psychiatry portfolios along with GlaxoSmithKline in a variety of pharmaceutical markets. Ms. Smith holds an B.Sc. (Hons) in Sports Therapy from the University College Chichester, UK.

Portrait

Neeraj Teotia Vice President, Marketing

Full Bio

Neeraj Teotia joined Nevro in 2014, and serves as Vice President of Marketing. He has held roles of increasing responsibility in marketing since joining Nevro as Director, Marketing. Prior to joining Nevro, Mr. Teotia served as a Director, New Business Development in the Global Surgery Group at Johnson & Johnson where he was responsible for assessing various licensing and acquisition opportunities. Prior to his role in New Business Development, Mr. Teotia worked in various Marketing, Licensing & Acquisitions and Research & Development roles within the medical device group at Johnson & Johnson. Mr. Teotia received a MBA from the Kellogg School of Management at Northwestern University and holds a BS in Electrical Engineering from the University of Illinois at Urbana-Champaign.

Our Board of Directors

The Board of Directors at Nevro includes veteran industry leaders with track records in bringing new therapies to market. We are fortunate to have the guidance of this strong group to help direct the growth of our company.

Michael DeMane Lead Director

Full Bio

Michael DeMane joined us in March 2011 and has served as our Chief Executive Officer and as Executive Chairman.  Effective January 1, 2017, Mr. DeMane transitioned to non-executive Chairman of the Board. Mr. DeMane has served on the board of directors of several private companies since 2009, as well as on the board of directors of eResearch Technology, Inc., a public company specializing in contract research clinical services, from July 2008 to April 2012. From March 2009 to June 2010, Mr. DeMane served as a Senior Advisor to Thomas, McNerney & Partners, a healthcare venture firm. Mr. DeMane served as the Chief Operating Officer of Medtronic from August 2007 to April 2008. Prior to his COO role, Mr. DeMane served at Medtronic as Senior Vice President from May 2007 to August 2007, Senior Vice President and President: Europe, Canada, Latin America and Emerging Markets from August 2005 to May 2007, Senior Vice President and President: Spinal, ENT and Navigation from February 2002 to August 2005, and President, Spinal from January 2000 to February 2002. Prior to that, he was President at Interbody Technologies, a division of Medtronic Sofamor Danek, Inc., from June 1998 to December 1999. From April 1996 to June 1998, Mr. DeMane served at Smith & Nephew Pty. Ltd. as Managing Director, Australia and New Zealand, after a series of research and development and general management positions with Smith & Nephew Inc. Mr. DeMane earned a B.S. in Chemistry from St. Lawrence University and an M.S. in Bioengineering from Clemson University. We believe that Mr. DeMane is qualified to serve on our Board due to his investment experience, strategic leadership track record, service on other boards of directors of companies in the healthcare industry and his previous service as our Chief Executive Officer.

Frank Fischer Chairman of the Board, NeuroPace, Inc.

Full Bio

Frank Fischer has more than 40 years of senior management experience in the medical device industry. He co-founded NeuroPace in Dec 1997, led the company as its President and Chief Executive Officer from January 2000 thru July 2019, served on its Board of Directors since inception and is currently Chairman of the Board. Prior to joining NeuroPace, Mr. Fischer was President and Chief Executive Officer of Heartport, Inc., a cardiac surgery company, from May 1998 until September 1999 and served on Heartport’s Board of Directors. Previously, Mr. Fischer was President and Chief Executive Officer and a director of Ventritex, Inc., a company that pioneered implantable cardiac defibrillators, from July 1987 until the sale of the company to St. Jude Medical, Inc. in 1997. Before joining Ventritex, he held various management positions at Cordis Corporation from 1977 to 1987 in the cardiac and neurosurgical device areas, serving most recently as President of the Implantable Products Division. Currently he is a member of the Board of Directors of Nevro, Inc., the Board of Trustees of both Rensselaer Polytechnic Institute and Babson College as well as the Board of Directors of the Epilepsy Foundation of America. Mr. Fischer holds B.S.M.E. and M.S. in Management degrees from Rensselaer Polytechnic Institute.

D. Keith Grossman Chairman, CEO & President

Full Bio

D. Keith Grossman joined us in March 2019 as our President and Chief Executive Officer. Mr. Grossman has over 30 years of experience in the medical device field. Mr. Grossman served most recently, and for the second time, as the President, Chief Executive Officer and director of Thoratec Corporation (“Thoratec”), leading up to its 2015 sale to St. Jude Medical. Prior to Thoratec, he served as President, Chief Executive Officer and director of Conceptus, a women’s health medical device company, leading up to its sale to Bayer Healthcare. Prior to Conceptus, Mr. Grossman served as managing director of Texas Pacific Group (“TPG”), a private equity firm, as a member of its healthcare investment team. Prior to TPG, Mr. Grossman served as Thoratec’s President, Chief Executive Officer and director for the first ten years of its growth as a commercial company. Mr. Grossman currently serves as chairman of the board of Outset Medical, Inc., a privately held company, as a board member of ViewRay, Inc. and previously served as a member of the board of directors of Intuitive Surgical, Inc., Kyphon, Inc., and a number of privately held medical device companies. Mr. Grossman received a B.S. in life sciences from The Ohio State University and an M.B.A. from Pepperdine University. We believe Mr. Grossman is qualified to serve on our Board due to his medical device company and industry experience, extensive leadership experience as the chief executive officer of medical device companies and service on other boards of directors.

Wilfred E. JaegerMD Three Arch Partners – Partner and Managing Member

Full Bio

Wilfred E. Jaeger has served on our Board since January 2012. Dr. Jaeger cofounded Three Arch Partners in 1993 and has served as a Partner and Managing Member since that time. Prior to co-founding Three Arch Partners, Dr. Jaeger was a general partner at Schroder Ventures. Dr. Jaeger currently serves on the board of directors and compensation committee of Concert Pharmaceuticals, Inc., a public clinical stage biopharmaceutical company, as well as numerous private companies. Dr. Jaeger received a B.S. in Biology from the University of British Columbia, an M.D. from the University of British Columbia School of Medicine and an M.B.A. from the Stanford Graduate School of Business. We believe that Dr. Jaeger is qualified to serve on our Board due to his investment experience, strategic leadership track record and service on other boards of directors of life sciences companies.

Shawn T. McCormick Former Medical Device Executive and CFO

Full Bio

Shawn T. McCormick has served on our Board since September 2014. Mr. McCormick served as Chief Financial Officer of Tornier N.V., a public medical device company (“Tornier”), from September 2012 to October 2015 when Tornier merged with Wright Medical Group. From April 2011 to February 2012, Mr. McCormick was Chief Operating Officer of Lutonix, Inc., a medical device company acquired by C. R. Bard, Inc. in December 2011. From January 2009 to July 2010, Mr. McCormick served as Senior Vice President and Chief Financial Officer of ev3 Inc., a public endovascular device company acquired by Covidien plc in July 2010. From May 2008 to January 2009, Mr. McCormick served as Vice President, Corporate Development at Medtronic, Inc., a public medical device company (“Medtronic”), where he was responsible for leading Medtronic’s worldwide business development activities. From 2007 to 2008, Mr. McCormick served as Vice President, Corporate Technology and New Ventures of Medtronic. From 2002 to 2007, Mr. McCormick was Vice President, Finance for Medtronic’s Spinal, Biologics and Navigation business. Prior to that, Mr. McCormick held various other positions with Medtronic, including Corporate Development Director, Principal Corporate Development Associate, Manager, Financial Analysis, Senior Financial Analyst and Senior Auditor. Prior to joining Medtronic, he spent four years with the public accounting firm KPMG Peat Marwick. He was a director of Entellus Medical, Inc., a public medical device company, and served as the chairman of the audit committee and as a member of the nominating and corporate governance committee from November 2014 to February 2018 when Entellus was sold to Stryker. Mr. McCormick has been a director of SurModics, Inc., a public medical device and in vitro diagnostic technologies company, since December 2015 and serves on the audit committee and corporate governance and nominating committee.  Mr. McCormick earned his M.B.A. from the University of Minnesota’s Carlson School of Management and his B.S. in Accounting from Arizona State University. He is a Certified Public Accountant (inactive license) and a National Association of Corporate Directors (NACD) Fellow. We believe that Mr. McCormick is qualified to serve on our Board due to his financial expertise and extensive operational experience in the medical device industry.

Kevin O'Boyle Director

Full Bio

Kevin O'Boyle has served on our Board since March 2019. Mr. O’Boyle has over 20 years of executive management experience in the medical device industry. Mr. O’Boyle currently serves as a director of each of Wright Medical Group N.V., GenMark Diagnostics, Inc. and Sientra, Inc. Previously, Mr. O’Boyle served as Senior Vice President and Chief Financial Officer of Advanced Biohealing Inc. a medical device company, from December 2010 until it was acquired in July 2011. Mr. O’Boyle served as CFO of NuVasive, Inc. from January 2003 until December 2009. Prior to that, Mr. O’Boyle served in various leadership positions during his six years with ChromaVision Medical Systems, Inc. Mr. O’Boyle received a B.S. in Accounting from the Rochester Institute of Technology and completed the Executive Management Program at the University of California Los Angeles, John E. Anderson Graduate Business School. We believe that Mr. O’Boyle is qualified to serve on our Board due to his financial expertise and extensive management experience in the medical device industry.

Brad ValePhD, DVM Former Head of Johnson & Johnson Development Company (JJDC)

Full Bio

Brad Vale has served on our Board since March 2015. Dr. Vale was Head of Johnson & Johnson Development Company (“JJDC”), from January 2012 to March 2015. Dr. Vale joined JJDC in March 1992 and was appointed to the position of Vice President, Head of Venture Investments in April 2008. From September 1989 to March 1992, Dr. Vale supported Johnson & Johnson’s medical device businesses at the Corporate Office of Science and Technology as an Executive Director. From 1982 to 1989, he was at Ethicon, Inc., a Johnson & Johnson subsidiary, working on preclinical studies, new business development, and a coronary artery bypass graft internal venture. Dr. Vale currently serves or has served on the board of directors of several private companies. Dr. Vale holds a Ph.D. from Iowa State University, a D.V.M. from Washington State University and a B.S. in Chemistry and Biology from Beloit College. We believe that Dr. Vale is qualified to serve on our Board due to his investment experience and strategic leadership in the life sciences industry.

Bess Weatherman Special Limited Partner, Warburg Pincus

Full Bio

Bess Weatherman joined us in March 2019 and currently serves as a member of our Board. Ms. Weatherman has served as special limited partner of Warburg Pincus LLC, a leading global private equity firm, since 2016. Ms. Weatherman joined Warburg Pincus in 1988, became a partner in 1996 and served as a member of the Executive Management Group from 2001 to January 2016. She led the firm’s Healthcare Group from 2008 to January 2015. Ms. Weatherman currently serves as a director of each of Wright Medical Group N.V., Vapotherm, Inc. and Silk Road Medical, Inc. She received a B.A. in English from Mount Holyoke College and an M.B.A. from Stanford Graduate School of Business. We believe that Ms. Weatherman is qualified to serve on our Board due to her service as a director on public company boards, including medical device companies, investment experience and healthcare industry knowledge.

Karen N. Prange Director

Full Bio

Ms. Prange was most recently Executive Vice President and Chief Executive Officer for the Global Animal Health, Medical and Dental Surgical Group at Henry Schein and a member of the Executive Committee. In this role, she led a business that generated over $6 billion of revenue across three different business units, growing the business to above-market levels in all business segments. Prior to her role at Henry Schein, she was SVP of Boston Scientific and President of its Urology and Pelvic Health business and served as General Manager of the Micrus Endovascular and Codman Neurovascular business at Johnson & Johnson Company. In addition to general management roles, Ms. Prange has extensive experience in commercial and operational roles, including managing innovation pipelines and acquiring and integrating companies. Ms. Prange currently serves on the boards of Atricure and Cantel Medical and is a strategic advisor for Nuvo Group. Ms. Prange earned her B.S. in Business Administration with honors from the University of Florida and has completed executive education coursework at UCLA Anderson School of Business and Smith College.